Table 3.
Per-Patient Reimbursement Costs, by Care Component at Time of Unscheduled Hydration
| Cost component | Per-patient reimbursement costsa |
Per-patient reimbursement costs (patients requiring additional care) |
||||
|---|---|---|---|---|---|---|
| SC granisetron ER cohort, $ (N = 91) | Palonosetron cohort, $ (N = 91) | P valueb | SC granisetron ER cohort, $ (N = 39) | Palonosetron cohort, $ (N = 72) | P valueb | |
| Unscheduled hydration | 62 | 253 | <.0001 | 146 | 320 | .0114 |
| Rescue antiemetic administration | 49 | 140 | <.0001 | 115 | 177 | .0227 |
| Rescue antiemetic drugs | 61 | 115 | <.0001 | 142 | 146 | .0953 |
| Laboratory | 16 | 50 | <.0001 | 38 | 63 | .0647 |
| Office evaluation | 108 | 279 | .0002 | 251 | 352 | .5942 |
| Total | 296c | 837d | <.0001 | 692 | 1058 | .0260 |
Values represent the mean.
P values are from Wilcoxon rank-sum test.
The median value for SC granisetron was $0.
The median value for palonosetron was $587.
ER indicates extended-release; SC, subcutaneous.